Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3244.5
(0.37%)
INR 3244.5
(0.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 25.33 Billion INR | 21.13% |
| 2022 | 21.13 Billion INR | 20.25% |
| 2021 | 17.57 Billion INR | -4.01% |
| 2020 | 18.3 Billion INR | 21.58% |
| 2019 | 15.05 Billion INR | 12.19% |
| 2018 | 13.42 Billion INR | 45.97% |
| 2017 | 9.19 Billion INR | -11.86% |
| 2016 | 10.43 Billion INR | -58.71% |
| 2015 | 25.27 Billion INR | 134.29% |
| 2014 | 10.78 Billion INR | 23.77% |
| 2013 | 8.71 Billion INR | 34.44% |
| 2012 | 6.48 Billion INR | 45.9% |
| 2011 | 4.44 Billion INR | 25.84% |
| 2010 | 3.53 Billion INR | -2.94% |
| 2009 | 3.63 Billion INR | 65.36% |
| 2008 | 2.19 Billion INR | 30.35% |
| 2007 | 1.68 Billion INR | 34.74% |
| 2006 | 1.25 Billion INR | 43.48% |
| 2005 | 872.85 Million INR | 44.37% |
| 2004 | 604.57 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 7.07 Billion INR | 3.97% |
| 2024 Q2 | 7.41 Billion INR | 4.81% |
| 2023 Q2 | 6.24 Billion INR | 4.0% |
| 2023 Q3 | 6.56 Billion INR | 5.13% |
| 2023 Q1 | 6 Billion INR | 12.99% |
| 2023 FY | 25.6 Billion INR | 21.13% |
| 2023 Q4 | 6.8 Billion INR | 3.66% |
| 2022 Q4 | 5.31 Billion INR | 0.0% |
| 2022 Q3 | 5.31 Billion INR | 2.91% |
| 2022 FY | 21.13 Billion INR | 20.25% |
| 2022 Q1 | 5.57 Billion INR | 57.79% |
| 2022 Q2 | 5.16 Billion INR | -7.36% |
| 2021 FY | 17.57 Billion INR | -4.01% |
| 2021 Q2 | 4.92 Billion INR | -3.91% |
| 2021 Q1 | 5.12 Billion INR | 12.67% |
| 2021 Q3 | 3.71 Billion INR | -24.59% |
| 2021 Q4 | 3.53 Billion INR | -4.85% |
| 2020 Q3 | 4.48 Billion INR | -5.88% |
| 2020 Q4 | 4.54 Billion INR | 1.43% |
| 2020 FY | 18.3 Billion INR | 21.58% |
| 2020 Q2 | 4.76 Billion INR | -5.56% |
| 2020 Q1 | 5.04 Billion INR | 37.86% |
| 2019 Q2 | 4.12 Billion INR | 2.74% |
| 2019 FY | 15.05 Billion INR | 12.19% |
| 2019 Q3 | 4.3 Billion INR | 4.37% |
| 2019 Q1 | 4.01 Billion INR | 1426.06% |
| 2019 Q4 | 3.65 Billion INR | -14.98% |
| 2018 Q3 | 4.08 Billion INR | 23.26% |
| 2018 Q2 | 3.31 Billion INR | -6.5% |
| 2018 FY | 13.42 Billion INR | 45.97% |
| 2018 Q4 | -302.4 Million INR | -107.41% |
| 2018 Q1 | 3.54 Billion INR | 38.82% |
| 2017 Q4 | 2.55 Billion INR | -24.78% |
| 2017 FY | 9.19 Billion INR | -11.86% |
| 2017 Q3 | 3.39 Billion INR | 4.95% |
| 2017 Q2 | 3.23 Billion INR | 0.31% |
| 2017 Q1 | 3.22 Billion INR | 6.62% |
| 2016 Q1 | 3.95 Billion INR | -11.83% |
| 2016 FY | 10.43 Billion INR | -58.71% |
| 2016 Q4 | 3.02 Billion INR | 3.07% |
| 2016 Q3 | 2.93 Billion INR | -3.62% |
| 2016 Q2 | 3.04 Billion INR | -23.04% |
| 2015 Q1 | 9.3 Billion INR | 409.0% |
| 2015 Q3 | 6.14 Billion INR | -15.78% |
| 2015 Q4 | 4.48 Billion INR | -27.04% |
| 2015 FY | 25.27 Billion INR | 134.29% |
| 2015 Q2 | 7.29 Billion INR | -21.61% |
| 2014 Q4 | 1.82 Billion INR | -27.21% |
| 2014 Q2 | 2.89 Billion INR | -22.52% |
| 2014 FY | 10.78 Billion INR | 23.77% |
| 2014 Q1 | 3.73 Billion INR | 19.47% |
| 2014 Q3 | 2.51 Billion INR | -13.15% |
| 2013 Q2 | 1.67 Billion INR | -14.36% |
| 2013 Q4 | 3.12 Billion INR | 53.05% |
| 2013 FY | 8.71 Billion INR | 34.44% |
| 2013 Q3 | 2.04 Billion INR | 22.16% |
| 2013 Q1 | 1.95 Billion INR | -3.15% |
| 2012 Q3 | 1.5 Billion INR | 2.74% |
| 2012 Q2 | 1.46 Billion INR | -2.67% |
| 2012 FY | 6.48 Billion INR | 45.9% |
| 2012 Q1 | 1.5 Billion INR | 72.73% |
| 2012 Q4 | 2.01 Billion INR | 34.23% |
| 2011 Q3 | 1.14 Billion INR | 0.0% |
| 2011 FY | 4.44 Billion INR | 25.84% |
| 2011 Q4 | 868.4 Million INR | -24.02% |
| 2010 FY | 3.53 Billion INR | -2.94% |
| 2009 FY | 3.63 Billion INR | 65.36% |
| 2008 FY | 2.19 Billion INR | 30.35% |
| 2007 FY | 1.68 Billion INR | 34.74% |
| 2006 FY | 1.25 Billion INR | 43.48% |
| 2005 FY | 872.85 Million INR | 44.37% |
| 2004 FY | 604.57 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -339.992% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 39.968% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -182.155% |
| Granules India Limited | 6.81 Billion INR | -271.663% |
| Indoco Remedies Limited | 1.29 Billion INR | -1860.096% |
| Achyut Healthcare Limited | 4.43 Million INR | -570769.761% |
| Ajanta Pharma Limited | 19.67 Billion INR | -28.753% |
| Alkem Laboratories Limited | 19.46 Billion INR | -30.178% |
| Alpa Laboratories Limited | 184.49 Million INR | -13632.039% |
| Brooks Laboratories Limited | 14.44 Million INR | -175351.524% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -1375.121% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -1958.097% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 62.593% |
| Eris Lifesciences Limited | 5.18 Billion INR | -388.934% |
| FDC Limited | 2.98 Billion INR | -748.407% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -289.63% |
| Gufic Biosciences Limited | 1.32 Billion INR | -1805.031% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -473.123% |
| Ipca Laboratories Limited | 7.98 Billion INR | -217.46% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -4885.968% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 16772.611% |
| Lasa Supergenerics Limited | -458 Million INR | 5631.643% |
| Laurus Labs Limited | 3.94 Billion INR | -541.625% |
| Lupin Limited | 28.04 Billion INR | 9.661% |
| Mankind Pharma Limited | 21.51 Billion INR | -17.739% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -25159.422% |
| Megasoft Limited | -121.1 Million INR | 21020.201% |
| NATCO Pharma Limited | 25.96 Billion INR | 2.414% |
| Piramal Pharma Limited | 4.55 Billion INR | -455.974% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1005.231% |
| Sigachi Industries Limited | 1.47 Billion INR | -1618.927% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 75.71% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -449.852% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -10064.533% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -4346.988% |
| Windlas Biotech Limited | 1.29 Billion INR | -1850.527% |
| ZIM Laboratories Limited | 253.82 Million INR | -9881.208% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 41.227% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 715.673% |
| Divi's Laboratories Limited | 33.08 Billion INR | 23.412% |
| Hester Biosciences Limited | 364.81 Million INR | -6844.766% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -809.375% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -5437.216% |
| Bal Pharma Limited | 233.9 Million INR | -10731.221% |
| Strides Pharma Science Limited | 5.22 Billion INR | -384.809% |
| Venus Remedies Limited | 534.65 Million INR | -4638.643% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -709.919% |
| Nectar Lifesciences Limited | 923.8 Million INR | -2642.481% |
| Shilpa Medicare Limited | 1.36 Billion INR | -1754.331% |
| Aarti Drugs Limited | 7.14 Billion INR | -254.402% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -1486.623% |
| Suven Life Sciences Limited | -1.22 Billion INR | 2166.793% |
| Ind-Swift Limited | 1.22 Billion INR | -1966.553% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | -77.382% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 757.562% |
| Themis Medicare Limited | 392.58 Million INR | -6353.365% |
| Hikal Limited | 32.11 Million INR | -78801.277% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -3943.927% |
| Wockhardt Limited | -670 Million INR | 3881.373% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -388.248% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -279269.7% |
| Neuland Laboratories Limited | 5.31 Billion INR | -376.396% |
| Morepen Laboratories Limited | 4.17 Billion INR | -507.001% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -12077.457% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -92168.92% |